1Nguyen LT,Tretiakova MS,Silvis MR,et al.ERG activates the YAP1transcriptional program and induces the development of age-related prostate tumors[J].Cancer Cell,2015,27(6):797-808.
2Dubovenko A,Serebryiskaya T,Nikolsky Y,et al.Reconstitution of the ERG gene expression network reveals new biomarkers and therapeutic targets in ERG positive prostate tumors[J].J Cancer,2015,6(6):490-501.
3Suryavanshi M,Mehta A,Jaipuria J,et al.Weaker ERG expression in patients with ERG-positive prostate cancer is associated with advanced disease and weaker androgen receptor expression:an Indian outlook[J].Urol Oncol,2015,33(7):9-15.
4Font-Tello A,Juanpere N,de Muga S,et al.Association of ERG and TMPRSS2-ERG with grade,stage,and prognosis of prostate cancer is dependent on their expression levels[J].Prostate,2015,75(11):1216-1226.
5Vnen RM,Ochoa NT,Bostrm PJ,et al.Altered PCA3and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates:a systematic,quantitative mRNA analysis in five prostates[J].BMC Urol,2015,15(1):88-89.
6Morais CL,Herawi M,Toubaji A,et al.PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas[J].Prostate,2015,75(14):1609-1610.
